CELAMPA M

Description

Composition: Empagliflozin and Metformin Hydrochloride

Product Type: Oral medication in tablet form.

Quantity: 14 tablets per pack.

Strength/Dosage:
12.5 mg of Empagliflozin with 500 mg of Metformin HCl
12.5 mg of Empagliflozin with 1000 mg of Metformin HCl

Dosage: As prescribed by a healthcare professional, typically taken with meals to reduce gastrointestinal side effects.

Indications:
Type 2 Diabetes Mellitus Management: Used to improve glycemic control in adults with Type 2 diabetes.
Complement to Lifestyle Changes: Effective when combined with diet and exercise to enhance blood sugar control.
Reduction of Cardiovascular Risk: Empagliflozin provides additional benefits in reducing cardiovascular risks in diabetic patients.
Dual Mechanism of Action:
Empagliflozin: Inhibits SGLT2, reducing glucose reabsorption and promoting glucose excretion.
Metformin: Reduces glucose production in the liver and improves insulin sensitivity.
Adjunct to Other Diabetes Medications: Can be used with other antidiabetic medications for comprehensive management when monotherapy is insufficient.